Back to top
more

IDEXX Laboratories, Inc. (IDXX)

(Real Time Quote from BATS)

$529.29 USD

529.29
178,292

-5.71 (-1.07%)

Updated Apr 19, 2021 02:51 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth F Momentum C VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (174 out of 254)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Zimmer Biomet (ZBH) Enhances ZBEdge Portfolio With Latest Suite

Zimmer Biomet's (ZBH) latest portfolio enhancement is aimed at improving patient outcome throughout the entire treatment process.

Omnicell's (OMCL) 2025 Roadmap Impressive, Pandemic Woe Stays

Omnicell (OMCL) expands its autonomous pharmacy portfolio with the acquisition of PSG's 340B Link business.

Here's Why You Should Hold on to Medtronic (MDT) Stock for Now

Investors continue to be optimistic about Medtronic (MDT) on its slew of product launches and regulatory approvals.

Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day

Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day

Urmimala Biswas headshot

COVID-19 Resurgence Accelerates Diagnostic Testing: 3 Top Picks

We have narrowed down our search to the following stocks, FLGT, BIO and IDXX based on a favorable Zacks Rank and strong prospects for 2021.

Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down

Walgreens Boots' (WBA) fiscal second-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.

Reasons to Hold on to Syneos Health (SYNH) Stock For Now

Investors continue to be optimistic about Syneos Health (SYNH) on solid sequential recovery of its operating segments and strategic partnerships.

Here's Why You Should Hold on to Ecolab (ECL) Stock for Now

Ecolab (ECL) continues to gain traction for a solid product portfolio and cost-efficiency program. However, segmental weakness is worrisome.

BD (BDX) Receives FDA EUA for Combination Rapid Antigen Test

BD (BDX) gets FDA EUA for new rapid, antigen test, which can distinguish between COVID-19, influenza A and influenza B in a single test.

Zacks Industry Outlook Highlights: Natus Medical, IDEXX Laboratories, Hologic, Thermo Fisher Scientific and Abiomed

Zacks Industry Outlook Highlights: Natus Medical, IDEXX Laboratories, Hologic, Thermo Fisher Scientific and Abiomed

Late-Breaking Data Supports Boston Scientific's (BSX) TheraSphere

Boston Scientific's (BSX) TheraSphere is expected to be used as a safe and effective treatment option for numerous HCC patients worldwide on the back of positive trial results.

Here's Why You Should Retain Henry Schein (HSIC) Stock For Now

Investors continue to be optimistic about Henry Schein (HSIC) on robust sales of PPE and COVID-19-related products.

Here's Why You Should Retain Merit Medical (MMSI) Stock Now

Merit Medical (MMSI) continues to gain traction on a solid product portfolio and strong international exposure. However, stiff competition is worrisome.

OPKO Health (OPK) BioReference Extends COVID-19 School Testing

OPKO Health's (OPK) BioReference expands COVID-19 testing in schools to create a safer learning environment for students, teachers, staff and their families.

Urmimala Biswas headshot

3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis

Despite the severe challenges posed by the COVID-19 pandemic, higher demand for telemedicine, digital influence and AI is likely to lend support to the Zacks Medical - Instruments industry. NTUS, IDXX and HOLX are well positioned to gain.

AmerisourceBergen (ABC) Hits New 52-Week High: What's Driving It?

AmerisourceBergen (ABC) is optimistic about maintaining a robust segmental performance amid the pandemic-led business disruptions.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain traction for solid product portfolio and improving margins. However, forex is a woe

Debanjana Dey headshot

5 MedTech Growth Stocks Gaining Ground in 2021 Amid Pandemic

Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.

Zacks.com featured highlights include: Toll Brothers, Goldman Sachs, Owens Corning, CBRE Group and IDEXX Laboratories

Zacks.com featured highlights include: Toll Brothers, Goldman Sachs, Owens Corning, CBRE Group and IDEXX Laboratories

Sanghamitra Saha headshot

5 Best Stocks Likely to Beat Earnings Estimates

These top-ranked stocks are likely to beat on the bottom lines in their next releases.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and robust product portfolio. However, high debt level remains a woe.

Idexx Laboratories (IDXX) Stock Moves -0.76%: What You Should Know

Idexx Laboratories (IDXX) closed at $487.66 in the latest trading session, marking a -0.76% move from the prior day.

New Study Favors Masimo's (MASI) Pulse Oximetry to Screen CCHD

The latest study highlights the efficacy of using Masimo's (MASI) SET pulse oximetry in screening CCHD in newborns.

Here's Why You Should Retain Glaukos (GKOS) Stock Right Now

Glaukos (GKOS) continues to benefit from robust product portfolio and solid performing iStent technology.

PRA Health (PRAH) Unveils Toolkit for Rare Disease Patients

PRA Health (PRAH) launches patient-focused toolkit to lower the burden on patients with rare diseases to participate in clinical research.